Prozac use in children

The licence for Prozac (fluoxetine) has been extended to include the treatment of moderate to severe major depressive episodes in children aged eight and above.

Treatment should be initiated and monitored by a specialist and should be offered to a child or young person with moderate to severe depression only in combination with concurrent psychological therapy.

The starting dose in children and adolescents aged eight and above is 10mg once daily, increasing if necessary to 20mg once daily after one or two weeks of treatment. Patients should be maintained at the lowest effective dose.

If no clinical benefit is achieved within nine weeks, treatment should be reconsidered. For patients who respond to treatment, the need for continued treatment after six months should be reviewed.

In a clinical trial decreased height and weight gain was observed in children and adolescents treated with fluoxetine. Growth and pubertal development should be monitored during and after treatment. If either is slowed, consider referral to a paediatrician.

Further information: Lilly 01256 315000

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more